Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Presence of Anemia and Poor Prognostic Factors in Patients with Endometrial Carcinoma

  • Wilairat, Wanitchar (Department of Obstetrics and Gynecology, Faculty of Medicine, Siriraj Hospital, Mahidol University) ;
  • Benjapibal, Mongkol (Department of Obstetrics and Gynecology, Faculty of Medicine, Siriraj Hospital, Mahidol University)
  • Published : 2012.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

This study evaluated the relationship between pretreatment hemoglobin (Hb) and prognostic factors in Thai patients with endometrial cancer. Medical records of 228 patients who had undergone surgery between January 2005 and December 2007 were retrospectively reviewed. Associations between clinicopathological variables and pretreatment Hb levels were described using Pearson's chi square test or two-tailed Fisher's exact test. Survival analysis was performed with Kaplan-Meier estimates. Univariate and Cox-regression models were used to evaluate the prognostic impact of various factors, including Hb levels, in term of disease-free survival. The median duration of follow-up was 38.2 months. Eighty-nine patients (39%) had a preoperative Hb level of <12 g/dL, these having significantly higher rates of non-endometrioid histology, advanced FIGO stage, lymphovascular space invasion, cervical involvement, adnexal involvement, positive peritoneal cytology, and lymph node involvement than patients with Hb ${\geq}12$ g/dL. The 5-year disease-free and overall survival were significantly lower in patients with pretreatment Hb levels <12 g/dL compared with those with Hb ${\geq}12$ g/dL (79.3% vs. 89.2%, p=0.044 and 87.6% vs. 99.3%, p<0.001, respectively). In the multivariate analysis only histology, myometrial invasion, and lymphovascular invasion proved to be independent prognostic factors, whereas tumor grading, stage, cervical involvement, adnexal involvement, positive peritoneal cytology, lymph node involvement, and low Hb were not. In conclusion, presence of anemia before treatment may reflect poor prognostic factors in patients with endometrial cancer and low pretreatment hemoglobin level may have a prognostic impact on clinical outcome.

Keywords

References

  1. Achariyapota V, Benjapibal M, Chaopotong P (2010). Prevalence and incidence of anemia in Thai patients with gynecologic cancer. Asian Pacific J Cancer Prev, 11, 1229-33.
  2. Alici S, Kaya S, Izmirli M, et al (2006). Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma. Med Sci Monit, 12, 221-9.
  3. Boogaerts M, Mittelman M, Vaupel P (2005). Beyond anaemia management: evolving role of erythropoietin therapy in neurological disorders, multiple myeloma and tumour hypoxia models. Oncology, 69, 22-30. https://doi.org/10.1159/000088285
  4. Bron D, Meuleman N, Mascaux C (2001). Biological basis of anemia. Semin Oncol, 28, 1-6. https://doi.org/10.1053/sonc.2001.19718
  5. Caro JJ, Salas M, Ward A, et al (2001). Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer, 91, 2214-21. https://doi.org/10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P
  6. Di Maio M, Pisano C, Tambaro R, et al (2006). The prognostic role of pre-chemotherapy hemoglobin level in patients with ovarian cancer. Front Biosci, 11, 1585-90. https://doi.org/10.2741/1906
  7. Dicato M (2003). Anemia in cancer: some pathophysiological aspects. Oncologist, 8, 19-21. https://doi.org/10.1634/theoncologist.8-suppl_1-19
  8. Dische S (1991). Radiotherapy and anaemia-the clinical experience. Radiother Oncol, 20, 35-40. https://doi.org/10.1016/0167-8140(91)90184-I
  9. Eichbaum MH, Weiss LM, Bruckner T, et al (2009). Prognostic impact of hemoglobin levels before and during carboplatin/taxane-based chemotherapy in patients with primary invasive epithelial ovarian cancer. Med Sci Monit, 15, 156-63.
  10. Eisenhauer EA, Vermorken JB, van Glabbeke M (1997). Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: a multivariate analysis of 704 patients. Ann Oncol, 8, 963-8. https://doi.org/10.1023/A:1008240421028
  11. Ferlay J, Shin HR, Bray F, et al (2010). Cancer incidence and mortality worldwide; in GLOBOCAN 2008, version 1.2. IARC CancerBase No. 10. Lyon, France, IARC. Availble from: http://www.dep.iarc.fr/globocan/globocan.htm.
  12. Gadducci A, Sartori E, Landoni F, et al (2005). Pre-chemotherapy hemoglobin levels and survival in patients with advanced epithelial ovarian cancer who received a first-line taxane/platinum-based regimen: results of a multicenter retrospective Italian study. Gynecol Oncol, 98, 118-23. https://doi.org/10.1016/j.ygyno.2005.04.012
  13. Gucer F, Moser F, Tamussino K, et al (1998). Thrombocytosis as a prognostic factor in endometrial carcinoma. Gynecol Oncol, 70, 210-4. https://doi.org/10.1006/gyno.1998.5078
  14. Graeber TG, Osmanian C, Jacks T, et al (1996). Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature, 379, 88-91. https://doi.org/10.1038/379088a0
  15. Hockel M, Vaupel P (2001). Biological consequences of tumor hypoxia. Semin Oncol, 28, 36-41. https://doi.org/10.1053/sonc.2001.25392
  16. Hockel M, Schlenger K, Aral B, et al (1996). Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res, 56, 4509-15.
  17. Knight K, Wade S, Balducci L (2004). Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med, 116, 11-26.
  18. Ludwig H, Van Belle S, Barrett-Lee P, et al (2004). The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer, 40, 2293-306. https://doi.org/10.1016/j.ejca.2004.06.019
  19. Liang BC (1996). Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines. J Neurooncol, 29, 149-55.
  20. Logsdon MD, Eifel PJ (1999). FIGO stage IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys, 43, 763-75. https://doi.org/10.1016/S0360-3016(98)00482-9
  21. Metindir J, Dilek GB (2009). Preoperative hemoglobin and platelet count and poor prognostic factors in patients with endometrial carcinoma. J Cancer Res Clin Oncol, 135, 125-9. https://doi.org/10.1007/s00432-008-0430-2
  22. Munstedt K, Kovacic M, Zygmunt M, et al (2003). Impact of hemoglobin levels before and during chemotherapy on survival of patients with ovarian cancer. Int J Oncol, 23, 837-43.
  23. Mercadante S, Gebbia V, Marrazzo A, et al (2000). Anaemia in cancer: pathophysiology and treatment. Cancer Treat Rev, 26, 303-11. https://doi.org/10.1053/ctrv.2000.0181
  24. Mundt AJ, Connell PP, Campbell T, et al (1998). Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapy. Gynecol Oncol, 71, 1511-5.
  25. Obermair A, Petru E, Windbichler G, et al (2000). Significance of pretreatment serum hemoglobin and survival in epithelial ovarian cancer. Oncol Rep, 7, 639-44.
  26. Obermair A, Handisurya A, Kaider A, et al (1998). The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients: a prospective review. Cancer, 83, 726-31. https://doi.org/10.1002/(SICI)1097-0142(19980815)83:4<726::AID-CNCR14>3.0.CO;2-U
  27. Pongsanon K, Benjapibal M, Ruengkhachorn I (2011). Prognostic significance of hemoglobin levels in patients with primary epithelial ovarian carcinoma undergoing platinum-based chemotherapy. Asian Pacific J Cancer Prev, 12, 131-6.
  28. Reynolds TY, Rockwell S, Glazer PM (1996). Genetic instability induced by the tumor microenvironment. Cancer Res, 56, 5754-7.
  29. Seshadri T, Prince HM, Bell DR, et al (2005). The Australian cancer anaemia survey: a snapshot of anaemia in adult patients with cancer. Med J Aust, 182, 453-7.
  30. Tas F, Eralp Y, Basaran M, et al (2002). Anemia in oncology practice: relation to diseases and their therapies. Am J Clin Oncol, 25, 371-9. https://doi.org/10.1097/00000421-200208000-00011
  31. Tamussino KF, Gucer F, Reich O, et al (2001). Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma. Int J Gynecol Cancer, 11, 236-40. https://doi.org/10.1046/j.1525-1438.2001.01024.x
  32. Thews O, Koenig R, Kelleher DK, et al (1998). Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia. Br J Cancer, 78, 752-6. https://doi.org/10.1038/bjc.1998.572
  33. Van Belle SJ, Cocquyt V (2003). Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy. Crit Rev Oncol Hematol, 47, 1-11. https://doi.org/10.1016/S1040-8428(03)00093-3
  34. Vaupel P, Mayer A, Briest S, et al (2003). Hockel M: Oxygenation gain factor: a novel parameter characterizing the association between hemoglobin level and the oxygenation status of breast cancers. Cancer Res, 63, 7634-7.
  35. Weiss G, Goodnough LT (2005). Anemia of chronic disease. N Engl J Med, 352, 1011-23. https://doi.org/10.1056/NEJMra041809
  36. Young SD, Marshall RS, Hill RP (1988). Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci USA, 85, 9533-7. https://doi.org/10.1073/pnas.85.24.9533

Cited by

  1. Risk Factors of Lymph Node Metastases with Endometrial Carcinoma vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6353
  2. Survival Rate of Early Stage Endometrioid Adenocarcinoma of Endometrium Treated at Srinagarind Hospital vol.15, pp.5, 2014, https://doi.org/10.7314/APJCP.2014.15.5.2217
  3. Incidence and Clinical Outcomes of Non-endometrioid Carcinoma of Endometrium: Siriraj Hospital Experience vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2905
  4. Predicting Lympho-Vascular Space Invasion in Endometrial Cancers with Mucinous Carcinomatous Components vol.16, pp.10, 2015, https://doi.org/10.7314/APJCP.2015.16.10.4247
  5. Malaria-induced anaemia and serum micronutrients in asymptomatic Plasmodium falciparum infected patients vol.41, pp.4, 2017, https://doi.org/10.1007/s12639-017-0940-4
  6. Prognostic value of pretreatment hemoglobin level in patients with early cervical cancer vol.57, pp.1, 2014, https://doi.org/10.5468/ogs.2014.57.1.28
  7. Transfusion Therapy: Is There a Link with Cancer Recurrence? pp.2167-6275, 2018, https://doi.org/10.1007/s40140-018-0292-3
  8. A prognostic parameter in advanced non-small cell lung cancer: the ratio of hemoglobin-to-red cell distribution width pp.1437-7772, 2019, https://doi.org/10.1007/s10147-019-01417-x